TY - JOUR
T1 - Ginkgo biloba
AU - Sierpina, Victor S.
AU - Wollschlaeger, Bernd
AU - Blumenthal, Mark
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease and dementia have been performed, and systematic reviews suggest the herb can improve the symptoms of dementia. Ginkgo is generally well tolerated, but it can increase the risk of bleeding if used in combination with warfarin, antiplatelet agents, and certain other herbal medications. Clinical issues of safety, dosing, use in the perioperative period, and pharmacology are addressed in this review.
AB - Ginkgo biloba is commonly used in the treatment of early-stage Alzheimer's disease, vascular dementia, peripheral claudication, and tinnitus of vascular origin. Multiple trials investigating the efficacy of ginkgo for treating cerebrovascular disease and dementia have been performed, and systematic reviews suggest the herb can improve the symptoms of dementia. Ginkgo is generally well tolerated, but it can increase the risk of bleeding if used in combination with warfarin, antiplatelet agents, and certain other herbal medications. Clinical issues of safety, dosing, use in the perioperative period, and pharmacology are addressed in this review.
UR - http://www.scopus.com/inward/record.url?scp=0041834580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041834580&partnerID=8YFLogxK
M3 - Review article
C2 - 13678141
AN - SCOPUS:0041834580
SN - 0002-838X
VL - 68
SP - 923
EP - 926
JO - American family physician
JF - American family physician
IS - 5
ER -